go to UNSW home page
UNSW logo Banner
SEARCH
  
Science
UNSW
BABS
Future Students
 
Undergraduate
Postgraduate
  PhD
  MSc
   2460
   8048
   2036
   8049
   2490
  Graduate Diploma
Honours
Graduate Diploma
Practicum
Scholarships
International
Careers
FAQs
Future Students > Postgraduate > MSc > 8049

8049 Master of Science Biopharmaceuticals

Average Duration: 1 year full-time or 2 years part-time

Requirements: Completion of 48 units of credit in program specified below

Award:
Master of Science (MSc)
 
2004 Session Starting Date
The Orientation Weekend for the Biopharm program will start on Saturday and Sunday, 31 January and 1 February. 2004.
Attendance is compulsory.

Time: Saturday - from 9 to 5 with happy hour after Sunday - from 9 to 1pm
Location:
Saturday - McCauley Theatre at the Quadrangle building.

Sunday - The library

If you can not attend the Orientation Weekend, you will need to defer your study to session 1, 2005.
You need to email Admissions Office to defer your study. Please find below contact details of the Admissions Office.
Tel: 612 9385 3656 Fax: 612 9662 1049
Email: Admita-g@unsw.edu.au(Last name A to G)
Admith-l@unsw.edu.au (Last name H to L)
Admitm-s@unsw.edu.au (Last name M to S)
admitt-z@unsw.edu.au (Last name T to Z)

Plans/Majors Available:
Biopharmaceuticals
 
School Contact:
Dr Christopher Marquis:
c.marquis@unsw.edu.au
 
Program Outline
This is an interdisciplinary program designed for graduates with backgrounds in either pharmacology or biotechnology who wish to obtain advanced training in both areas in order to gain expertise necessary for the development and use of the new generation of biopharmaceuticals which have been developed by, or result from, the application of molecular biology.

The program teaches the scientific bases underscoring the development of recombinant biopharmaceuticals, combined with aspects of clinical trials, regulatory considerations, patent issues and licensing. The program content is incorporated in courses that can be delivered either by distance or "on campus" mode.
The courses are comprised of written text containing program materials, demonstrations and self-testing exercises. For Distance students, one day of face-to-face teaching is provided per course. In addition, there is access to the course coordinators by phone e-mail and teleconferencing facilities and tutorials for on campus students.
 
Admission Requirements
It is open to graduates with a four-year degree in a related discipline or who have, in the opinion of the Higher Degree Committee, acquired equivalent qualifications or experience. Prior study of biochemistry is required for the program.
 
 
Program Structure
The Master of Science in Biopharmaceuticals program calls for the completion of eight courses, equivalent to 48 units of credit in total. The program is run in two by twenty week sessions and can be completed in one year full-time. Part-time students can enrol in two courses per session, allowing the program to be completed in two years part-time.
 
Master of Science in Biopharmaceuticals (On Campus)

Summer Session (X1)
PHPH9101 Principles of Drug Action (6 UOC)

Session 1
BIOT7070 Recombinant Protein Expression Systems (6 UOC)
PHPH9100 Discovery and Development of Medicines (6 UOC)
BIOT7180 Biotechnology Project 1 (6 UOC)
 
Session 2
BIOT7160 Genomics and Proteomics (6 UOC)
BIOT7080 Biopharmaceutical Production Processes (6 UOC)
BIOT7170 Therapeutic Modalities Biopharmaceutical (6 UOC)
BIOT7190 Biotechnology Project 2 (6 UOC)
 
Master of Science in Biopharmaceuticals (Distance*)
*Note:
Distance education mode is designed for students residing in Australia only.

Summer Session (X1)
PHPH9101 Principles of Drug Action (6 UOC)
 
Session 1
BIOT7070 Recombinant Protein Expression Systems (6 UOC)
PHPH9100 Discovery and Development of Medicines (6 UOC)
BIOT7120 Business, Licensing and Patenting (6 UOC)
 
Session 2
BIOT7160 Genomics and Proteomics (6 UOC)
BIOT7080 Biopharmaceutical Production Processes (6 UOC)
BIOT7170 Therapeutic Modalities Biopharmaceutical (6 UOC)
PHPH9120 Clinical Development of New Medicines (6 UOC)